In the coming weeks, the FDA is poised to greenlight a groundbreaking medical therapy. Exa-Cel is a revolutionary gene-editing treatment that treats sickle cell disease. Learn more about the first CRISPR therapy to seek FDA approval and then bring this…
Read More In the News: Exa-Cel Gene Therapy, CRISPR, and Sickle Cell Disease
The Official Blog of Edvotek® 